NCT02886611 Limbal Stem Cell Deficiency of Genetic Origin: Genotype-phenotype Correlation
| NCT ID | NCT02886611 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild |
| Condition | Limbus Corneae |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2015-12-15 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2015-12-15 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims at searching for a genotype-phenotype correlation in patients with a genetic pathology of the ocular surface, in order to identify genetic abnormalities associated with the most severe clinical situations.
Eligibility Criteria
Inclusion Criteria: * genetic pathology of ocular surface Exclusion Criteria: * Agonal glaucoma * Low vision mostly related to retinal pathology * Pregnant or breast feeding patient
Contact & Investigator
Anna GEMAHLING, MD
PRINCIPAL INVESTIGATOR
Hôpital Fondation Adolphe de Rothschild
Frequently Asked Questions
Who can join the NCT02886611 clinical trial?
This trial is open to participants of all sexes, studying Limbus Corneae. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02886611 currently recruiting?
Yes, NCT02886611 is actively recruiting participants. Contact the research team at ayavchitz@for.paris for enrollment information.
Where is the NCT02886611 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT02886611 clinical trial?
NCT02886611 is sponsored by Fondation Ophtalmologique Adolphe de Rothschild. The principal investigator is Anna GEMAHLING, MD at Hôpital Fondation Adolphe de Rothschild. The trial plans to enroll 60 participants.